viral
replic
depend
host
small
genom
virus
need
hijack
host
cellular
machineri
complet
life
cycl
coevolut
intim
relationship
led
mani
virus
abl
success
propag
without
signific
detriment
effect
host
howev
instanc
viral
infect
caus
diseas
molecular
mechan
underli
diseas
focu
advanc
summer
school
africa
held
hermanu
south
africa
march
assembl
coastal
town
hermanu
particip
primarili
phd
student
postdoc
less
develop
countri
speaker
leader
respect
field
around
world
fig
school
second
kind
africa
sponsor
intern
union
biochemistri
molecular
biolog
iubmb
feder
european
biochem
societi
feb
feder
african
societi
biochemistri
molecular
biolog
unit
nation
educ
scientif
cultur
organ
intern
centr
genet
engin
biotechnolog
icgeb
cours
honor
presenc
brian
clark
professor
biostructur
chemistri
univers
aarhu
denmark
prof
clark
renown
scientist
particip
discoveri
initi
codon
protein
synthesi
first
crystal
trna
today
prof
clark
studi
molecular
cellular
mechan
age
use
system
biolog
approach
presenc
particularli
signific
summer
school
sinc
involv
organ
sever
similar
event
tenur
presid
iubmb
feb
notabl
spets
summer
school
prof
clark
stress
import
meet
develop
young
scientist
scienc
main
theme
discuss
summer
school
viral
infect
lead
cancer
greater
understand
mechan
underpin
human
immunodefici
viru
hiv
propag
inform
new
antivir
strategi
abil
virus
evad
immun
system
obstacl
develop
effect
vaccin
potenti
afford
virus
research
tool
import
host
factor
becam
appar
discuss
topic
viral
research
inform
gener
knowledg
cell
biolog
report
serv
summaris
find
present
summer
school
dr
lawrenc
bank
icgeb
triest
provid
overview
hpv
role
viral
protein
transform
cervic
epitheli
cell
almost
cervic
cancer
contain
hpv
dna
usual
type
despit
statist
cancer
induct
part
normal
hpv
life
cycl
rare
case
lack
immun
clearanc
lead
persist
infect
along
addit
chang
cell
cancer
develop
bank
describ
hpv
major
viral
oncoprotein
involv
develop
cervic
cancer
hpv
life
cycl
critic
depend
differenti
epitheli
cell
usual
dna
replic
cell
basement
layer
hpv
induc
phase
creat
permiss
environ
viral
replic
addit
target
cellular
substrat
degrad
notabl
tumor
suppressor
prb
respect
hpv
dna
exist
episom
form
may
found
integr
malign
cell
integr
often
involv
loss
viral
dna
inde
malign
cell
often
display
viral
replic
maintain
express
emphas
role
protein
cancer
progress
hpv
infect
result
malign
issu
tackl
dr
john
doorbar
nation
institut
medic
research
london
cancer
predomin
tissu
other
case
cervic
cancer
report
year
contrast
penil
cancer
rare
case
per
year
despit
evid
dispar
primari
infect
rate
impli
differ
propens
hpv
form
neoplast
lesion
differ
site
doorbar
specul
due
grade
abil
hpv
replic
differ
tissu
evid
caus
wart
lesion
mucos
site
doorbar
believ
transform
zone
cervix
may
particularli
suscept
neoplasia
format
exact
host
factor
respons
variat
hpv
replic
abil
unresolv
doorbar
group
also
investig
molecular
basi
differ
outcom
result
hpv
infect
hpv
gene
express
occur
order
manner
infect
cell
move
epitheli
tissu
doorbar
describ
host
protein
mini
chromosom
mainten
protein
could
use
marker
cell
prolifer
thu
surrog
activ
express
lower
layer
hpv
lesion
shown
laser
captur
microscopi
viral
protein
abundantli
express
upper
layer
interestingli
doorbar
group
shown
squamou
intraepitheli
lesion
hsil
associ
increas
express
upper
epitheli
layer
almost
express
reveal
viral
express
pattern
reflect
sever
diseas
addit
prolifer
basal
cell
stop
basement
layer
complet
lesion
contrast
lesion
increas
basal
layer
prolifer
correl
activ
level
drive
increas
activ
infect
unknown
wound
heal
episom
copi
number
dna
methyl
pattern
host
genet
background
could
contribut
requir
investig
nevertheless
observ
potenti
tremend
improv
exist
cervic
screen
practic
reli
heavili
cytolog
though
vitro
studi
invalu
identifi
candid
molecul
involv
pathogenesi
conform
role
often
requir
vivo
approach
dr
paul
f
lambert
univers
wisconsin
medic
school
describ
transgen
mous
model
hpv
human
keratin
promot
use
drive
express
hpv
gene
stratifi
squamou
epithelia
previou
studi
shown
express
hpv
gene
insuffici
caus
cervic
cancer
mice
lambert
group
hypothes
estrogen
cofactor
cervic
cancer
gener
receptor
transgen
mice
develop
cervic
cancer
may
account
observ
year
contracept
pill
usag
pregnanc
increas
risk
women
develop
cervic
cancer
hpv
associ
cancer
cervix
howev
prof
iqbal
parker
icgeb
cape
town
show
papilloma
virus
typic
consid
could
involv
fatal
cancer
oesophagu
parker
group
found
oesophag
cancer
oc
patient
integr
dna
tumor
brush
biopsi
healthi
peopl
confirm
hpv
enrich
oc
patient
howev
smoke
alcohol
home
brew
consumpt
cook
indoor
fire
conjunct
certain
allel
also
risk
factor
associ
develop
oc
africa
whether
hpv
infect
earli
initi
event
oc
develop
requir
investig
molecular
alter
direct
progress
product
infect
hsil
hpv
infect
fulli
understood
hpv
oncoprotein
alon
capabl
transform
shown
human
keratinocyt
vitro
murin
cervic
epithelia
vivo
rather
papilloma
oncogenesi
requir
supplementari
genet
chang
occur
time
follow
initi
infect
whilst
clear
integr
viral
dna
host
genom
crucial
tumor
develop
whether
caus
consequ
chromosom
instabl
clear
despit
activ
variou
oncogen
hpv
protein
viral
dna
integr
cancer
develop
often
follow
import
host
includ
abil
regul
viral
gene
express
differ
tissu
mount
effect
immun
respons
becom
increasingli
appar
determin
molecular
basi
tumor
progress
dr
ethel
cesarman
weill
cornel
medic
colleg
describ
human
herp
virus
focus
kshv
also
known
human
herp
viru
kshv
caus
cancer
often
found
immunosuppress
individu
suffer
aid
includ
karposi
sarcoma
primari
effus
lymphoma
multicentr
castleman
diseas
kshv
seropreval
africa
hpv
major
individu
present
diseas
kshv
contain
orf
least
accessori
gene
among
accessori
gene
identifi
date
name
kshv
g
receptor
becom
major
focu
investig
though
express
small
number
ks
lesion
spindl
cell
known
involv
cell
transform
induct
angiogen
cytokin
express
exampl
vascular
endotheli
growth
factor
one
cytokin
secret
cell
express
induc
prolifer
angiogenesi
ks
tissu
follow
observ
protein
express
lymphomagen
virus
latent
infect
activ
cesarman
group
search
viral
protein
whose
activ
correl
identifi
vflip
homologu
cflip
protein
show
sirna
induc
apoptosi
cell
work
continu
develop
drug
hope
prove
effect
agent
lectur
dr
ingemar
ernberg
karolinska
institut
stockholm
recoin
acronym
ebv
everi
bodi
viru
human
infect
childhood
though
infect
typic
subclin
member
hhv
famili
ebv
initi
isol
burkitt
lymphoma
cell
line
though
later
found
associ
number
differ
tumor
undifferenti
nasopharyng
carcinoma
hodgkin
diseas
nasal
cell
lymphoma
gastric
carcinoma
ernberg
describ
four
program
latent
viral
gene
express
viral
gene
express
associ
cell
prolifer
therefor
ernberg
group
look
signal
control
switch
show
low
express
viral
gene
high
level
cellular
transcript
factor
vice
versa
work
ongo
deciph
reason
decreas
level
concomit
switch
program
gene
express
hope
shed
light
ebv
set
point
vari
individu
differ
b
cell
appear
immun
ebv
infect
major
popul
suscept
dr
aluisio
segurado
univers
paulo
describ
retroviru
result
adult
cell
leukemialymphoma
atll
myelopathi
hamtsp
estim
million
individu
infect
worldwid
yet
vast
major
remain
clinic
develop
atll
reason
low
frequenc
diseas
unknown
segurado
hypothesis
host
genet
environment
factor
play
role
rather
infect
differ
strain
htlv
tax
one
protein
act
transcript
activ
atll
howev
low
incid
rate
long
latenc
period
prior
develop
atll
suggest
addit
viral
infect
accumul
mutat
host
gene
requir
cellular
transform
vivo
among
hepat
virus
hbv
hcv
caus
chronic
infect
lead
develop
cirrhosi
hepatocellular
carcinoma
hcc
hbv
dna
viru
integr
host
genom
dr
shahid
jameel
icgeb
new
delhi
describ
integr
deregul
express
viral
protein
hbx
abl
induc
hcc
either
alon
synergi
differ
cellular
protein
jameel
also
discuss
tumorigenesi
induc
hcv
chronic
inflamm
associ
oxid
chromosom
dna
damag
probabl
play
role
interact
viral
protein
prb
may
also
predispos
carcinogenesi
although
virus
discuss
induc
pathway
cancer
parallel
drawn
requir
viral
oncogen
indic
virus
play
crucial
role
progress
malign
rna
dna
tumor
virus
promot
growth
infect
tissu
activ
cellular
oncogen
inactiv
tumor
suppressor
gene
interestingli
mani
cellular
oncogen
tumor
suppressor
gene
eg
prb
identifi
studi
rna
dna
tumor
virus
respect
infect
virus
establish
either
latent
hpv
ebv
kshv
chronic
hbv
hcv
infect
activ
latent
infect
may
result
chang
cell
environ
accumul
viral
stress
cell
andor
decreas
abil
host
maintain
latenc
clear
infect
activ
signal
may
depend
host
genet
epigenet
factor
understand
individu
infect
tumor
virus
develop
cancer
remain
critic
anticip
continu
research
distinguish
normal
viral
life
cycl
life
cycl
malign
tissu
chang
host
factor
accompani
transform
address
problem
far
demonstr
chang
viral
gene
express
may
accompani
develop
lesion
eg
hpv
ebv
chang
occur
low
frequenc
infect
popul
chang
gene
express
result
interact
disrupt
answer
question
requir
great
deal
research
certainli
speaker
summer
school
cours
lentivirus
abil
infect
termin
differenti
nondivid
cell
therefor
requir
nuclear
import
howev
revers
transcript
complex
rtc
larger
nuclear
pore
diffus
size
limit
addit
rtc
enrich
nucleic
acid
must
overcom
hydrophob
exclus
nuclear
pore
complex
concentr
gradient
dna
enter
nucleu
manner
resolv
dilemma
worth
investig
nuclear
import
critic
transmiss
aid
pathogenesi
dr
fassati
group
identifi
novel
mechan
enter
nucleu
number
viral
element
shown
play
role
nuclear
import
eg
cppt
element
nuclear
local
signal
within
matrix
viral
protein
integras
vpr
fassati
group
interest
identifi
host
nuclear
transport
receptor
respons
import
use
purifi
rtc
complex
primari
macrophag
show
importin
involv
import
receptor
ribosom
histon
protein
respect
work
reveal
role
correl
abil
bind
hiv
knockdown
decreas
import
dna
rna
indic
revers
transcript
requir
nuclear
import
dna
like
hijack
facilit
import
dna
genom
although
remain
unclear
whether
rtc
remain
intact
throughout
nuclear
import
process
fassati
group
continu
search
nuclear
import
pathway
use
nucleic
acid
rtc
cell
treat
digitonin
permeabilis
plasma
nuclear
membran
monitor
nuclear
import
presenc
variou
cytosol
extract
almost
homogen
fraction
capabl
induc
nuclear
import
rtc
found
contain
trna
show
nuclear
import
least
speci
trna
occur
uninfect
cell
previous
undescrib
cellular
pathway
unknown
function
appear
exploit
trna
present
virion
specul
promot
nuclear
import
rtc
via
associ
host
factor
yet
identifi
fassati
work
describ
novel
import
pathway
thu
identifi
potenti
drug
target
also
enhanc
knowledg
cellular
biolog
identif
trna
nuclear
import
pathway
latent
viral
reservoir
establish
earli
hiv
infect
prevent
erad
viru
suscept
antiretrovir
treatment
addit
latent
provir
dna
reactiv
replenish
viral
load
interrupt
treatment
therefor
understand
molecular
mechan
govern
latenc
reactiv
viral
express
crucial
develop
strategi
aim
complet
erad
viru
end
dr
marcello
describ
work
impact
chromatin
chromosom
territori
control
transcript
latenc
marcello
shown
histon
methyltransferas
protein
histon
trimethyl
enrich
transcript
silent
provir
dna
rnai
target
allevi
chromatin
repress
gene
express
pbmc
donor
whilst
provid
insight
mechan
underli
latenc
question
remain
cell
come
latent
infect
repress
chromatin
architectur
provir
ltr
given
propens
integr
activ
transcript
unit
nucleu
highli
dynam
organis
entiti
wide
accept
activ
transcript
enrich
nuclear
peripheri
marcello
group
examin
latent
infect
cell
line
cell
develop
jordan
et
al
fish
show
along
activ
viral
transcript
occur
nuclear
peripheri
latent
proviru
locat
peripheri
chromatin
conform
captur
analysi
reveal
associ
latent
proviru
pericentromer
region
chromosom
tran
lost
reactiv
transcript
although
rule
latenc
result
rare
integr
event
inact
gene
nuclear
peripheri
marcello
work
support
model
integr
activ
gene
clonal
expans
activ
cell
popul
follow
number
cell
becom
quiescent
memori
cell
chanc
transit
accompani
repress
proviru
epigenet
mechan
disrupt
repress
chromatin
manner
ongo
challeng
host
cell
crowd
environ
assembl
virion
need
form
stabl
structur
produc
cell
virion
need
rapidli
destabilis
upon
entri
new
cell
differ
virus
evolv
differ
solut
paradox
hiv
solut
provid
gag
polyprotein
initi
stabl
immatur
virion
spheric
capsid
shell
compos
gag
form
matur
sequenti
cleavag
gag
polyprotein
proteas
pr
result
rearrang
virion
form
matur
infecti
viru
conic
capsid
compos
sole
capsid
ca
domain
gag
despit
chang
overal
size
virion
dr
h
g
provid
overview
work
detail
mechan
viru
releas
immatur
matur
virion
transit
studi
reveal
follow
proteolyt
matur
gag
matur
capsid
contain
ca
protein
assembl
hexamer
lattic
complet
spheric
immatur
capsid
predict
contain
gag
polyprotein
doubl
number
present
matur
core
subsequ
cryoelectron
tomographi
studi
demonstr
fact
gag
arrang
incomplet
spheric
hexagon
lattic
addit
contain
hole
hole
may
serv
allevi
strain
impart
lattic
curvatur
evid
pentamer
defect
observ
matur
core
differ
arrang
gag
deriv
immatur
matur
stage
may
indic
disassembl
immatur
shell
prior
assembl
matur
core
extent
disassembl
unclear
process
would
attract
drug
target
immatur
viru
contain
incomplet
shell
viru
releas
cell
previous
thought
gag
assembl
plasma
membran
spheric
shell
result
membran
bud
subsequ
cleavag
result
thin
membran
tether
cellular
endosom
sort
complex
requir
transport
escrt
machineri
group
demonstr
almost
complet
gag
sphere
present
site
function
escrt
absent
along
observ
immatur
shell
compos
incomplet
gag
sphere
propos
novel
model
releas
virion
bud
initi
gag
assembl
escrt
recruit
earli
drive
releas
process
therefor
consid
kinet
competit
assembl
occur
faster
escrt
recruit
releas
incomplet
use
total
intern
reflect
fluoresc
tirf
microscopi
group
abl
confirm
atpas
appear
burst
site
particl
product
earli
gag
assembl
further
understand
role
anoth
host
factor
releas
known
restrict
factor
downregul
hiv
accessori
protein
vpu
howev
rodent
mous
potent
inhibit
releas
resist
vpu
consequ
develop
small
anim
model
hiv
infect
work
marcello
fassati
reveal
continu
effort
discern
molecular
mechan
replic
facilit
develop
effect
antivir
approach
applic
pathogen
virus
immun
system
import
curtail
detriment
effect
hpv
infect
lesion
observ
sever
combin
immunodefici
scid
patient
detect
hpv
dna
women
may
due
chang
immun
system
dr
j
doorbar
describ
immun
system
struggl
clear
hpv
langerhan
cell
effect
viral
protein
express
low
level
lower
epitheli
layer
addit
hpv
protein
downregul
cytokin
interferon
respect
also
thought
play
immunosuppress
role
inhibit
major
histocompat
mhc
matur
henc
without
intervent
wart
verruca
take
month
disappear
also
delay
immun
clearanc
viru
may
predispos
individu
cancer
fortun
hpv
vaccin
avail
whilst
effect
vaccin
protect
two
predomin
type
protect
nevertheless
widespread
administr
vaccin
would
greatli
reduc
cervic
cancer
health
burden
fear
influenza
pandem
envelop
world
recent
year
prof
j
l
virelizi
pasteur
institut
pari
address
immun
respons
viru
typic
human
success
erad
influenza
follow
product
antibodi
although
viru
transfer
anoth
individu
prior
antibodi
product
fear
pandem
born
concern
gene
reassort
give
rise
viru
abl
infect
human
caus
fatal
antibodi
envelop
protein
haemagglutinin
ha
protect
influenza
howev
viru
abl
avoid
immun
system
antigen
drift
period
antigen
shift
latter
potenti
caus
pandem
passiv
transfer
polyclon
antibodi
specif
influenza
ha
protect
homolog
viru
infect
mice
transfer
ha
antibodi
highlight
problem
influenza
protect
requir
antibodi
need
taken
consider
vaccin
develop
virelizi
also
discuss
relev
lymphocyt
memori
antivir
immun
respons
describ
origin
antigen
sin
phenomenon
immunis
one
variant
boost
anoth
recal
antibodi
also
antibodi
determin
exampl
immunis
ha
strain
protect
anoth
strain
eg
improv
primari
respons
anoth
variant
year
later
relat
dual
function
b
cell
antibodi
produc
antigen
present
cell
immunis
prime
cell
via
b
cell
antigen
present
b
cell
antibodi
product
thu
follow
primari
exposur
anoth
variant
cell
help
facilit
rapid
antibodi
respons
includ
newli
encount
epitop
import
vaccin
administr
practic
emphasis
import
vaccin
older
member
societi
also
young
afford
lymphocyt
memori
sever
acut
respiratori
syndrom
sar
first
report
asia
within
month
viru
spread
countri
asia
north
america
south
america
europ
prof
lui
enjuan
consejo
superior
de
investigacion
cientifica
csic
madrid
gave
detail
lectur
develop
vaccin
group
demonstr
recombin
viru
protect
balbc
mice
fatal
respiratori
diseas
challeng
partli
protect
mice
express
viral
receptor
hamster
immunis
show
decreas
lung
inflamm
clinic
ill
challeng
recombin
strain
also
induc
antiviru
cell
antibodi
respons
work
ongo
elucid
role
e
differenti
gene
express
studi
implic
regul
stress
respons
whilst
highli
promis
vaccin
yet
consid
safe
human
particularli
given
preval
coronavirus
risk
recombin
exist
vaccin
product
involv
chemic
attenu
also
carri
safeti
concern
inactiv
incomplet
use
rather
wild
type
chemic
attenu
could
improv
safeti
vaccin
product
without
compromis
immunogen
hiv
infect
million
peopl
worldwid
mostli
develop
world
nearli
half
individu
die
epidem
driven
part
exquisit
abil
hiv
evad
immun
system
dr
jameel
discuss
variou
mechan
use
hiv
escap
host
immun
system
multifunct
hiv
accessori
protein
nef
optimis
cellular
environ
viral
replic
via
associ
number
host
factor
shown
nef
abl
downregul
express
major
histocompat
molecul
mhc
protein
jameel
group
also
identifi
role
nef
downregul
costimulatori
molecul
ongo
work
investig
potenti
role
anoth
hiv
accessori
protein
vpu
decreas
antigen
present
interact
mhcii
invari
chain
given
abil
hiv
evad
immun
system
success
consider
effort
devot
develop
vaccin
despit
decad
research
effect
vaccin
remain
elus
three
characterist
hiv
infect
point
difficulti
associ
develop
effect
vaccin
persist
replic
cellular
humor
immun
escap
immunosuppress
neutralis
antibodi
shown
provid
protect
primat
model
dr
jeffrey
dorfman
icgeb
cape
town
describ
believ
success
vaccin
would
elicit
broadli
neutralis
antibodi
bnab
dorfman
hope
identifi
novel
bnab
screen
sera
pseudoviru
neutralis
assay
bnab
use
identif
epitop
inform
vaccin
design
identif
bnab
hamper
howev
technic
difficulti
associ
isol
product
particularli
rare
dorfman
develop
novel
method
product
involv
fusion
pbmc
myeloma
sidestep
requir
transform
prof
carolyn
williamson
univers
cape
town
discuss
genet
bottleneck
hiv
transmiss
ie
singl
virus
establish
infect
interestingli
strain
appear
bode
well
vaccin
whether
infecti
advantag
mucos
site
less
stabl
viral
envelop
like
expos
conserv
epitop
unclear
although
nab
basi
protect
antivir
vaccin
concern
efficaci
prevent
infect
bnab
respons
would
suffici
strong
rapid
mucos
site
prevent
infect
even
bnab
unabl
neutralis
viru
transmit
virolog
synaps
due
steric
hindranc
addit
viru
contain
epitop
rapidli
select
therefor
matter
broad
nab
like
vaccin
would
need
elicit
number
bnab
increas
protect
nevertheless
bnab
way
confer
sterilis
immun
still
holi
grail
hiv
vaccin
design
scientist
believ
effect
vaccin
elicit
cytotox
lymphocyt
ctl
respons
howev
prof
j
l
virelizi
describ
preced
ctl
anim
viru
kill
cell
cytotox
mechan
convers
williamson
report
studi
reveal
correl
specif
hla
allel
breadth
hiv
lymphocyt
respons
control
viral
replic
although
conflict
result
cours
correl
causat
say
cell
immun
protect
ctl
inject
mous
liver
express
hbv
transgen
result
decreas
viral
replic
histolog
reveal
protect
confer
cytotox
mechan
rather
product
replic
restor
presenc
antibodi
cell
activ
also
confer
protect
hiv
product
chemokin
rant
host
ligand
hiv
coreceptor
respect
chemokin
block
hiv
entri
compet
hiv
receptor
virelizi
describ
abil
truncat
inhibit
hiv
infect
whilst
longer
act
agonist
truncat
prevent
signal
g
protein
report
howev
hiv
use
coreceptor
includ
bob
complic
use
chemokin
mimic
therapi
addit
chemokin
suffer
limit
bnab
virolog
synaps
although
cell
activ
antivir
product
interferon
chemokin
may
sword
virelizi
propos
hypothesi
cell
activ
contribut
persist
replic
signal
initi
hiv
transcript
nevertheless
given
help
cell
provid
b
cell
antibodi
product
like
ideal
hiv
vaccin
would
elicit
humor
cellular
immun
school
thought
vaccin
requir
prevent
death
patient
die
result
immunosuppress
convers
primat
abl
surviv
siv
infect
indefinit
immun
system
destroy
virelizi
specul
therefor
research
focus
combat
immunosuppress
summari
understand
immun
respons
viral
pathogen
critic
counteract
viral
evas
immun
respons
discern
respons
protect
inform
vaccin
design
enhanc
abil
induc
effect
antivir
immun
respons
reduc
probabl
diseas
beyond
enorm
health
concern
aros
sar
epidem
major
econom
loss
caus
famili
virus
coronavirus
cov
potenti
promis
deliveri
vector
vaccin
develop
gene
therapi
highlight
cours
present
dr
l
enjuan
mechan
transcript
use
coronavirida
famili
emphasis
import
rna
chaperon
transcrib
viral
genom
essenti
effici
cov
replic
enjuan
group
identifi
cov
transcript
enhanc
base
long
distanc
interact
transmiss
gastroenter
coronaviru
tgev
addit
discoveri
transcript
regulatori
sequenc
permit
genet
manipul
improv
gene
express
well
enhanc
basic
knowledg
cov
biolog
find
facilit
develop
safe
success
deliveri
vector
advantag
cov
possess
virus
express
vector
includ
possibl
spike
protein
manipul
engin
viru
tropism
replic
rna
genom
cytoplasm
potenti
problem
associ
integr
exist
nonpathogen
strain
infect
wide
rang
speci
health
econom
import
abil
carri
larg
genom
kb
could
favor
introduct
extens
foreign
gene
avail
cdna
clone
deriv
infecti
strain
two
express
system
develop
base
cov
one
express
system
product
larg
amount
heterolog
antigen
cell
achiev
synthesi
retain
around
viral
passag
addit
singl
genom
cov
vector
either
construct
target
recombin
use
infecti
cov
cdna
clone
deriv
tgev
genom
system
shown
express
foreign
gene
least
passag
demonstr
high
stabil
ongo
research
explor
possibl
manipul
speci
tissu
tropism
cov
express
system
enjuan
work
reveal
cov
vector
flexibl
robust
tool
potenti
aid
vaccin
product
gene
therapi
diseas
may
aris
number
reason
viru
replic
suboptim
host
tissu
emerg
new
pathogen
variant
accumul
detriment
effect
infect
clearanc
fail
enhanc
suscept
host
research
molecular
basi
viru
infect
propag
enhanc
understand
diseas
inform
new
antivir
strategi
vaccin
design
addit
way
virus
har
mean
emerg
particip
summer
school
learnt
great
deal
approach
work
research
present
school
embodi
good
scienc
also
great
atmospher
fig
epitomis
inclus
everyon
birthday
celebr
speaker
l
enjuan
j
l
virelizi
inform
interact
throughout
plenti
time
alloc
discuss
ensur
particip
gain
invalu
input
lectur
allow
particip
present
work
school
stimul
discuss
led
new
collabor
opportun
would
afford
develop
countri
scientist
without
summer
school
